Mesenchymal stem cell insights: Prospects in hematological transplantation

Cell Transplantation

Volumn 22, Issue 4, 2013, Pages 711-721

  Chou, Shiu Huey ^a   Lin, Shinn Zong ^b   Day, Cecilia Hsuan ^c   Kuo, Wei Wen ^b   Shen, Chia Yao ^c   Hsieh, Dennis Jine Yuan ^b   Lin, Jing Ying ^d   Tsai, Fuu Jen ^e   Tsai, Chang Hai ^b   Huang, Chih Yang ^b,f  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

Bone marrow (BM); Hematopoiesis; Hematopoietic niche; Hematopoietic stem cells (HSCs); Mesenchymal stem cells (MSCs)

Indexed keywords

BONE MARROW CELL; CELL CONTACT; CELL HOMING; CELL INTERACTION; EXTRACELLULAR MATRIX; HEMATOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTHESIS; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; STEM CELL NICHE;

ANIMALS; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS; STEM CELL NICHE;

EID: 84876459952     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655172     Document Type: Review

References (80)

1. Aggarwal, S.; Pittenger, M. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Asari, S.; Itakura, S.; Ferreri, K.; Liu C. P.; Kuroda, Y.; Kandeel, F.; Mullen, Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 37(5):604-615; 2009.
3. Augello, A.; Tasso R.; Negrini S. M.; Amateis A.; Indiveri F.; Cancedda R.; Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35:1482-1490; 2005.
4. Ball, L. M.; Bernardo, M. E.; Roelofs, H.; Lankester, A.; Cometa, A.; Egeler, R. M.; Locatelli, F.; Fibbe, W. E. Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stemcell transplantation. Blood 110:2764-2767; 2007.
5. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48; 2002.
6. Bernardo, M. E.; Ball, L. M.; Cometa, A. M.; Roelofs, H.; Zecca, M.; Avanzini, M. A.; Bertaina, A.; Vinti, L.; Lankester, A.; Maccario, R.; Ringden, O.; Le Blanc, K.; Egeler, R. M.; Fibbe, W. E.; Locatelli, F. Coinfusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GvHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant. 46:200-207; 2011.
7. Bernardo, M. E.; Locatelli, F.; Fibbe, W. E. Mesenchymal stromal cells: A novel treatment modality for tissue repair. Ann. N.Y. Acad. Sci. 1176:101-117; 2009.
8. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219; 2005.
9. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98:1076-1084; 2006.
10. Chou, S. H.; Kuo, T. K.; Liu, M.; Lee, O. K. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice. J. Orthop. Res. 24(3):301-312; 2006.
11. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367-372; 2006.
12. Dao, M.; Hashino, K.; Kato, I.; Nolta, J. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 92:4612-4621; 1998.
13. Devine, S.; Bartholomew, A.; Mahmud, N.; Nelson, M.; Patil, S.; Hardy, W.; Sturgeon, C.; Hewett T.; Chung T.; Stock W.; Sher D.; Weissman S.; Ferrer K.; Mosca J.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells are capable of homing to the bone marrow of nonhuman primates following systemic infusion. Exp. Hematol. 29:244-255; 2001.
14. Dexter, T. M.; Allen, T. D.; Lajtha, L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 91:335-344; 1977.
15. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
16. Friedenstein, A.; Petrakova, K.; Kurolesova, A.; Frolova, G. Heterotopic transplants of bone marrow. Transplantation 6:230-247; 1968.
17. Galotto, M.; Berisso, G.; Delfino, L.; Podesta, M.; Ottaggio, L.; Dallorso, S.; Dufour, C.; Ferrara, G. B.; Abbondandolo, A.; Dini, G.; Bacigalupo, A.; Cancedda, R.; Quarto, R. Stromal damage as consequence of high-dose chemo/ radiotherapy in bone marrow transplant recipients. Exp. Hematol. 27:1460-1466; 1999.
18. Gao, J.; Dennis, J. E.; Muzic, R.; Lundberg, M.; Caplan, A. The dynamic in vivo distribution of bone marrowderived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20; 2001.
19. Gieseke, F.; Böhringer, J.; Bussolari, R.; Dominici, M.; Handgretinger, R.; Müller, I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116(19):3770-3779; 2010.
20. Gonzalo-Daganzo, R.; Regidor, C.; Martín-Donaire, T.; Rico, M.; Bautista, G.; Krsnik, I.; Forés, R.; Ojeda, E.; Sanjuán, I.; García-Marco, J.; Navarro, B.; Gil, S.; Sánchez, R.; Panadero, N.; Gutiérrez, Y.; García-Berciano, M.; Pérez, N.; Millán, I.; Cabrera, R.; Fernández, M. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11:278-288; 2009.
21. Gottschling, S.; Saffrich, R.; Seckinger, A.; Krause, U.; Horsch, K.; Miesala, K.; Ho, A. D. Human mesenchymal stroma cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a β1-integrin-dependent mechanism. Stem Cells 25:798-806; 2007.
22. Heike, T.; Nakahata, T. Ex vivo expansion of hematopoietic stem cells by cytokines. Biochem. Biophys. Acta 1592(3):313-321; 2002.
23. Highfill, S.; Kelly, R.; O'Shaughnessy, M.; Zhou, Q.; Xia, L.; Panoskaltsis-Mortari, A.; Taylor, P.; Tolar, J.; Blazar, B. Multipotent adult progenitor cells can suppress graftversus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood 114:693-701; 2009.
24. Hiwase, S.; Dyson, P.; To, L.; Lewis, I. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/ severe combined immune deficient mice. Stem Cells 27:2293-2300; 2009.
25. Horwitz, E.; Le Blanc, K.; Dominici, M.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Deans, R.; Krause, D.; Keating, A. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395; 2005.
26. Ivanovic, Z.; Hermitte, F.; Brunet, G.; Dazey, B.; Belloc, F.; Lacombe, F.; Vezon, G.; Praloran, V. Simultaneous maintenance of human cord blood SCID repopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells 22:716-724; 2004.
27. Kiel, M.; Yilmaz, O.; Iwashita, T.; Yilmaz, O.; Terhorst, C.; Morrison, S. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109-1121; 2005.
28. Kim, D.; Chung, Y.; Kim, T.; Kim, Y.; Oh, I. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 103:1941-1948; 2004.
29. Klyushnenkova, E.; Mosca, J. D.; Zernetkina, V.; Majumdar, M.; Beggs, K.; Simonetti, D.; Deans, R.; McIntosh, K. T-cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12:47-57; 2005.
30. Koc, O.; Gerson, S.; Cooper, B.; Dyhouse, S.; Haynesworth, S.; Caplan, A.; Lazarus, H. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18:307-316; 2000.
31. Krampera, M.; Glennie, S.; Dyson, J.; Scott, D.; Laylor, R.; Simpson, E.; Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T-cells to their cognate peptide. Blood 101:3722-3729; 2003.
32. Kuçi, S.; Kuçi, Z.; Kreyenberg, H.; Deak, E.; Pütsch, K.; Huenecke, S.; Amara, C.; Koller, S.; Rettinger, E.; Grez, M.; Koehl, U.; Latifi-Pupovci, H.; Henschler, R.; Tonn, T.; von Laer, D.; Klingebiel, T.; Bader, P. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftmentpromoting properties. Haematologica 95:651-659; 2010.
33. Lazarus, H.; Haynesworth, S.; Gerson, S.; Rosenthal, N.; Caplan, A. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant. 16:557-564; 1995.
34. Lazarus H.; Koc O.; Devine S.; Curtin P.; Maziarz R.; Holland H.; Shpall, E.; McCarthy, P.; Atkinson, K.; Cooper, B.; Gerson, S.; Laughlin, M.; Loberiza, F.; Moseley, A.; Bacigalupo, A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11:389-398; 2005.
35. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Götherström, C.; Hassan, M.; Uzunel, M.; Ringdén, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
36. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringdén, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
37. Liechty, K.; MacKenzie, T.; Shaaban, A.; Radu, A.; Moseley, A.; Deans, R.; Marshak, D.; Flake, A. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6(11):1282-1286; 2000.
38. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90:516-525; 2005.
39. MacMillan, M.; Blazar, B.; DeFor, T.; Wagner, J. Transplantation of ex vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant. 43:1-8; 2008.
40. Maitra, B.; Szekely, E.; Gjini, K.; Laughlin, M.; Dennis, J.; Haynesworth, S.; Koç, O. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33:597-604; 2004.
41. Majumdar, M.; Keane-Moore, M.; Buyaner, D.; Hardy, W.; Moorman, M.; McIntosh, K.; Mosca, J. Charactierization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10:228-241; 2003.
42. Majumdar, M.; Thiede, M.; Haynesworth, S.; Bruder, S.; Gerson, S. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J. Hematother. Stem Cell Res. 9(6):841-848; 2000.
43. Masuda, S.; Ageyama, N.; Shibata, H.; Obara, Y.; Ikeda T; Takeuchi, K.; Ueda, Y.; Ozawa, K.; Hanazono, Y. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates. Exp. Hematol. 37:1250-1257; 2009.
44. Méndez-Ferrer, S.; Michurina, T.; Ferraro, F.; Mazloom, A.; Macarthur, B.; Lira, S.; Scadden, D.; Ma'ayan, A.; Enikolopov, G.; Frenette, P. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834; 2010.
45. Metcalf, D. On hematopoietic stem cell fate. Immunity 26(6):669-673; 2007.
46. Nauta, A.; Westerhuis, G.; Kruisselbrink, A.; Lurvink, E.; Willemze, R.; Fibbe, W. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a non-myeloablative setting. Blood 108:2114-2120; 2006.
47. Nilsson, S.; Debatis, M.; Dooner, M.; Madri, J.; Quesenberry, P.; Becker, P. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J. Histochem. Cytochem. 46:371-377; 1998.
48. Noort, W.; Kruisselbrink, A.; in't Anker, P.; Kruger, M.; van Bezooijen, R.; de Paus, R.; Heemskerk, M.; Löwik, C.; Falkenburg, J.; Willemze, R.; Fibbe, W. Mesenchymal stem cells promote engraftment of human umbilical cord bloodderived CD34+ cells in NOD/SCID mice. Exp. Hematol. 30:870-878; 2002.
49. Ortiz, L.; Gambelli, F.; McBride, C.; Gaupp, D.; Baddoo, M.; Kaminski, N.; Phinney, D. Mesenchymal stem cells engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100:8407-8411; 2003.
50. Osawa, M.; Hanada, K.; Hamada, H.; Nakauchi, H. Longterm lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273(5272):242-245; 1996.
51. Pereira, R.; O'Hara, M.; Laptev, A.; Halford, K.; Pollard, M.; Class, R.; Simon, D.; Livezey, K.; Prockop, D. Marrow stroma cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl. Acad. Sci. USA 95:1142-1147; 1998.
52. Pevsner-Fischer, M.; Morad, V.; Cohen-Sfady, M.; Rousso-Noori, L.; Zanin-Zhorov, A. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432; 2007.
53. Pittenger, M.; Mackay, A.; Beck, S.; Jaiswal, R.; Douglas, R.; Mosca, J.; Moorman, M.; Simonetti, D.; Craig, S.; Marshak, D. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
54. Potian, J. A.; Aviv, H.; Ponzio, N. M.; Harrison, J. S.; Rameshwar, P. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171:3426-3434; 2003.
55. Puch, S.; Armeanu, S.; Kibler, C.; Johnson, K. R.; Muller, C. A.; Wheelock, M. J.; Klein, G. N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J. Cell Sci. 114:1567-1577; 2001.
56. Punzel, M.; Gupta, P.; Verfaillie, C. The microenvironment of AFT024 cells maintains primitive human hematopoiesis by counteracting contact mediated inhibition of proliferation. Cell Commun. Adhes. 9:149-159; 2002.
57. Punzel, M.; Liu, D.; Zhang, T.; Eckstein, V.; Miesala, K.; Ho, A. D. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp. Hematol. 31:339-347; 2003.
58. Raicevic, G.; Najar, M.; Stamatopoulos, B.; De Bruyn, C.; Meuleman, N.; Bron, D.; Toungouz, M.; Lagneaux, L. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell. Immunol. 270:207-216; 2011.
59. Rasmusson, I.; Ringdén, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213; 2003.
60. Sagar, B.; Rentala, S.; Gopal, P.; Sharma, S.; Mukhopadhyay, A. Fibronectin and laminin enhance engraftibility of cultured hematopoietic stem cells. Biochem. Biophys. Res. Commun. 350:1000-1005; 2006.
61. Salem, H. K.; Thiemermann, C. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28(3):585-596; 2010.
62. Sioud, M.; Mobergslien, A.; Boudabous, A.; Fløisand, Y. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scan. J. Immunol. 71:267-274; 2010.
63. Sugiyama, T.; Kohara, H.; Noda, M.; Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977-988; 2006.
64. Taichman, R.; Emerson, S. Human osteoblasts support hematopoiesis through the production of granulocyte colony stimulating factor. J. Exp. Med. 179:1677-1682; 1994.
65. Tolar, J.; Le Blanc, K.; Keating, A.; Blazar, B. Concise review: Hitting the right spot with mesenchymal stromal cells. Stem Cells 28:1446-1455; 2010.
66. Tse, W.; Pendleton, J.; Beyer, W.; Egalka, M.; Guinan, E. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397; 2003.
67. Uccelli, A.; Pistoia, V.; Moretta, L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol. 28(5):219-226; 2007.
68. Ueda, T.; Tsuji, K.; Yoshino, H.; Ebihara, Y.; Yagasaki, H.; Hisakawa, H. Expansion of human NOD/SCIDrepopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin,IL-6, and soluble IL-6 receptor. J. Clin. Invest. 105(7):1013-1021; 2000.
69. Wagner, W.; Roderburg, C.; Wein, F.; Diehlmann, A.; Frankhauser, M.; Schubert, R.; Eckstein, V.; Ho, A. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25:2638-2647; 2007.
70. Wagner, W.; Wein, F.; Roderburg, C.; Saffrich, R.; Diehmann, A.; Eckstein, V.; Ho, A. Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44. Cells Tissues Organs 188(1-2):160-169; 2008.
71. Wagner, W.; Wein, F.; Roderburg, C.; Saffrich, R.; Faber, A.; Krause, U.; Schubert, M.; Benes, V.; Eckstein, V.; Maul, H.; Ho, A. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp. Hematol. 35:314-325; 2007.
72. Weiss, L. The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rats. Anat. Rec. 186:161-184; 1976.
73. Wynn, R.; Hart, C.; Corradi-Perini, C.; O'Neill, L.; Evans, C.; Wraith, J.; Fairbairn, L.; Bellantuono, I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645; 2004.
74. + stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis. Stem Cells 25:1800-1806; 2007.
75. Yoshikubo, T.; Inoue, T.; Noguchi, M.; Okabe, H. Differentiation and maintenance of mast cells from CD34+ human cord blood cells. Exp. Hematol. 34:320-329; 2006.
76. Zangi, L.; Margalit, R.; Reich-Zeliger, S.; Bachar-Lustig, E.; Beilhack, A.; Negrin, R.; Reisner, Y. Direct imagingof immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27:2865-2874; 2009.
77. Zhang, J.; Niu, C.; Ye, L.; Huang, H.; He, X.; Tong, W. G.; Ross, J.; Haug, J.; Johnson, T.; Feng, J. Q.; Harris, S.; Wiedemann, L. M.; Mishina, Y.; Li, L. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841; 2003.
78. Zhang, W.; Ge, W.; Li, C.; You, S.; Liao, L.; Han, Q.; Deng, W.; Zhao, R. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocytederived dendritc cells. Stem Cell Dev. 12:263-271; 2004.
79. Zhao, L.; Duan, W.; Reyes, M.; Keene, C.; Verfaillie, C.; Low, W. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174:11-20; 2002.
80. Zipori, D.; Duksin, D.; Tamir, M.; Argaman, A.; Toledo, J.; Malik, Z. Cultured mouse marrow stromal cell lines, II. Distinct subtypes differing in morphology, collagen types, myelopoietic factors, and leukemic cell growth modulating activities. J. Cell. Physiol. 122:81-90; 1985.